Concepedia

Rosa Coppolecchia

RC

4

Publications

1.1K

Citations

4

H-Index

2018

Active since

Affiliations

Duke University(Current)

Bayer (United States)

NYU Langone Health

Harvard University

Clinical Research Institute

Rosa Coppolecchia is an author at Duke University specializing in medicine, thrombosis, and anesthesiology.

Top concepts

Publications per year

2018–2024

4

Publications

4

Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial

J. Michael Gaziano, Carlos Brotons, Rosa Coppolecchia et al. · The Lancet · 2018 · 849 citations · Full text

, , +10

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

Sunil V. Rao, Bodo Kirsch, Deepak L. Bhatt et al. · Circulation · 2022 · 142 citations · Full text

Asundexian versus Apixaban in Patients with Atrial Fibrillation

Jonathan P. Piccini, Manesh R. Patel, Jan Steffel et al. · New England Journal of Medicine · 2024 · 117 citations · Full text

Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials

John W. Eikelboom, Hardi Mundl, John H. Alexander et al. · Journal of the American College of Cardiology · 2024 · 10 citations

Rows per page

1–4 of 4